Overview

Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate whether the experimental drug ulipristal acetate can shrink uterine fibroids in pre-menopausal women.
Phase:
Phase 2
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator:
HRA Pharma
Treatments:
Progesterone
Ulipristal acetate